Leafbuyer Technologies, Inc. Announces Record Results: 38% Increase in Quarterly Revenue and 53% Increase in Gross Margins

November 20, 2024 8:00 AM

Financial Highlights:Revenue rose 38% from $1,169,622 to $1,609,473 in the second quarter of fiscal year 2024Revenue Increase was more than 11X Industry Growth RateExpanding Profit Margins: Gross Margins increased 53% Year to YearGross Profit increased 110% from $356,278 to $749,281 in the same periodDENVER, CO / ACCESSWIRE / November 20, 2024 / Leafbuyer Technologies Inc. (OTCQB:LBUY) ("Leafbuyer" or "the Company"), a leading cannabis...

Read more

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

November 20, 2024 7:44 AM

MIAMI, FL / ACCESSWIRE / November 20, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company, is pleased to announce the selection of The Centre for Human Drug Research (CHDR) in Leiden, The Netherlands, as the site for its Phase I/IIa clinical trial of Ketamir-2, a novel oral ketamine analog. Recruitment for the trial is set to begin in Q1 2025, with initial safety and efficacy results from the Phase I study...

Read more

UniDoc Showcases H3 Health Cube in Italy

November 20, 2024 7:30 AM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is pleased to announce that its H3 Health Cube has been selected to be featured at the 41st Annual Assembly of National Association of Italian Municipalities (ANCI). The event venue is the Lingotto in Turin from November 20 to 22, with UniDoc featured at Booth #106.Key Highlights:H3 Health Cube on Display at Annual Assembly of...

Read more

PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report

November 20, 2024 7:30 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / November 20, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS), a leader in digital healthcare solutions, announces a delay in the release of its Q3 2024 financial results. The updated release date has been set for 29th November 2024.The delay is due to the ongoing consolidation of newly acquired companies, the administrative follow-up from the recent successful funding round, and the...

Read more

AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm

November 20, 2024 4:20 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / November 20, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company's CEO Martin Jönsson will present at Stora Aktiedagarna in Stockholm, hosted by Aktiespararna, at 08:50 CET on November 27.During the day,...

Read more

Consumers Primed to Spend on Cannabis, New Poll Finds

November 19, 2024 4:00 PM

A majority of frequent cannabis consumers say their spending on cannabis has gone up during the past year, and a plurality say they expect it to continue to rise over the next year, according to a new consumer poll released today by NuggMD.The poll shows 61% of respondents report spending "more" or "much more" on cannabis over the past year. Forty-five percent said they expect their spending on cannabis products to continue to rise over the next...

Read more

Glen and Michelle Scharfeld of Senior Helpers Spotlighted in an In-Depth Feature on Compassionate Elderly Care

November 19, 2024 3:30 PM

Founders of Senior Helpers, Glen and Michelle Scharfeld, have been featured in a profound online feature piece titled "Senior Helpers: Glen and Michelle Scharfeld's Commitment to Compassionate Elderly Care." This detailed profile showcases their journey from community-oriented individuals to leaders in the senior care industry, focusing on their dedication to quality service, innovation, and compassionate care practices.Originally from Florida,...

Read more

MMJ Disrupts DEA Marijuana Hearing Process - Judge, Jury, Executioner Game Over

November 19, 2024 1:15 PM

The long-standing administrative practices of the DEA are under heightened scrutiny as the agency faces constitutional challenges questioning the legitimacy of its quasi-judicial processes. Among the most significant of these challenges is the lawsuit filed by MMJ BioPharma Cultivation, which contends that the DEA's administrative proceedings are unconstitutional. Recent legal precedents, such as the Supreme Court's decision in SEC v. Jarkesy...

Read more

Paragon Health IT to Elevate Imaging as a Service Offering With Advanced Performance Monitoring and Workflow Automation

November 19, 2024 12:00 PM

SACRAMENTO, CA / ACCESSWIRE / November 19, 2024 / Paragon Health IT today announced a collaboration with Dell Technologies. Paragon's flagship product, Strings by Paragon, will enhance Dell's Medical Imaging as a Service offering by providing real-time performance monitoring, seamless architecture management, and the ability to create automated workflows across the enterprise - all within a unified, single-pane-of-glass interface. With the...

Read more

Despite High Levels of Confidence, Women Entrepreneurs Still Face Systemic Barriers

November 19, 2024 11:31 AM

Women entrepreneurs across the globe are highly confident in business. Yet they remain blocked from economic opportunity by flawed systemsATLANTA, GA / ACCESSWIRE / November 19, 2024 / Women entrepreneurs are deeply confident in their own abilities and prospects, according to new research from CARE's Women's Entrepreneurship team. They are strategically expanding their client bases, building supplier networks, and making critical business...

Read more

Owen Mumford Awarded Safety Phlebotomy and Specimen Collection Products Agreement With Premier, Inc.

November 19, 2024 11:30 AM

MARIETTA, GA / ACCESSWIRE / November 19, 2024 / Owen Mumford has been awarded a national group purchasing agreement for Safety Phlebotomy and Specimen Collection Products with Premier, Inc. Effective December 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing terms pre-negotiated by Premier for Unistik® safety fingerstick lancets, heel incision devices and safety blood collection...

Read more

Michelle Klinedinst, Founder of ViaMar Health, Featured in Exclusive Interview on Compassionate Eating Disorder Treatment

November 19, 2024 11:15 AM

Michelle Klinedinst, the founder of ViaMar Health, has been spotlighted in an inspiring and insightful online interview that delves into her personal and professional journey in establishing one of Florida's most respected eating disorder treatment centers. The interview sheds light on Michelle's deep-rooted passion for creating safe and holistic spaces for those suffering from eating disorders and co-occurring mental health conditions. Her...

Read more

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe”

November 19, 2024 9:30 AM

SAN FRANCISCO, CA / ACCESSWIRE / November 19, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Jaguar family company Napo Therapeutics has been named "Best Pharmaceuticals Innovator of the Year - Europe" by The European, a quarterly business publication published by CP Media Global Ltd in London."We are very honored to receive this award," said Massimo Radaelli, PhD, Chief Executive Officer of Napo Therapeutics and...

Read more

Physiowell Approach: Personalized Care for Every Patient

November 19, 2024 9:30 AM

DUBAI, UAE / ACCESSWIRE / November 19, 2024 / Located in the heart of Dubai, Physiowell has redefined physiotherapy by focusing on personalized treatments customized for each individual. Dedicated to developing individualized physiotherapy treatment plans, they guarantee expert physiotherapy care specifically designed to address personal needs. This tailored method not only improves health but also strives to achieve the best possible recovery...

Read more

WoundZoom Announces Launch of the WoundZoom LIGHT Mobile Application for Post Acute Care

November 19, 2024 9:00 AM

BOCA RATON, FL / ACCESSWIRE / November 19, 2024 / WoundZoom is thrilled to introduce WoundZoom LIGHT, a HIPAA-compliant point-of-care mobile application designed specifically for post-acute wound care clinicians. WoundZoom LIGHT provides an intuitive interface enabling automated documentation, patient workflow management, and advanced measurement imaging in online or offline care settings. "We are excited about the introduction of WoundZoom...

Read more

Global Wound Filler Market Set for Steady Growth, projected to Reach USD 948.7 Million by 2034 with a 4.4% of CAGR | Future Market Insights, Inc.

November 19, 2024 8:30 AM

The Wound Filler Market, valued at USD 614.7 million in 2024, is projected to grow at a steady CAGR of 4.4%, reaching USD 948.7 million by 2034. This growth is driven by rising cases of chronic wounds, technological advancements in wound care products, and increased healthcare spending across emerging markets.Key innovations such as antimicrobial fillers and bioengineered solutions are playing a significant role in reshaping the wound care...

Read more

CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary

November 19, 2024 8:00 AM

With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.SCOTTSDALE, AZ / ACCESSWIRE / November 19, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a pioneering force in the CBD and cannabis industries, is proud to announce the signing of a pivotal Letter of Intent (LOI) to acquire an interest in a cannabis dispensary located in New...

Read more

Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate

November 19, 2024 7:30 AM

Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK, CA / ACCESSWIRE / November 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that the company will host a conference call and webcast to announce its oral peptide IL-17 antagonist development candidate and to share in vitro and pre-clinical proof-of-concept study results.Conference Call and...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group's B_FIT brand

November 19, 2024 7:00 AM

AUSTIN, TX / ACCESSWIRE / November 19, 2024 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that, Armah Sports Group's B_FIT is installing CLMBRs across three of the brand's nine locations in Saudi Arabia.Trent Ward, Co-Founder and CEO of TRNR, said: "Armah Sports Group and the Al Hagbani family are pioneers of the fitness...

Read more

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab

November 19, 2024 4:30 AM

LINDIS Biotech GmbH, a clinical stage biopharmaceutical company with a proprietary multi-specific antibody platform and an advanced development pipeline in immuno-oncology, today announced a licensing agreement with global pharmaceutical company Pharmanovia for catumaxomab, for the treatment of malignant ascites.The agreement gives Pharmanovia the exclusive rights to bring to market, catumaxomab, a first-in-class, trifunctional bi-specific...

Read more